tadalafil has been researched along with Weight Gain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, Y; Inamura, S; Ito, H; Kobayashi, H; Nagase, K; Taga, M; Yokoyama, O; Zha, X | 1 |
| Jia, H; Levine, MA; Qin, L; Tower, RJ; Wang, L | 1 |
2 other study(ies) available for tadalafil and Weight Gain
| Article | Year |
|---|---|
Phosphodiesterase 5 inhibitor suppresses prostate weight increase in type 2 diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin-Like Growth Factor I; Male; Phosphodiesterase 5 Inhibitors; Prostate; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Tadalafil; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Weight Gain | 2022 |
Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats.
Topics: Animals; Animals, Newborn; Bone and Bones; Bone Development; Cancellous Bone; Chondrocytes; Cortical Bone; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Epiphyses; Male; Natriuretic Peptide, C-Type; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tadalafil; Weight Gain; X-Ray Microtomography | 2018 |